Abbott Laboratories (ABT) vs Medtronic PLC (MDT)
- Abbott Laboratories ABT 110.32 −2.89%
- Medtronic PLC MDT 102.05 −2.66%
Abbott Laboratories and Medtronic PLC are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $134.1B — 1.5× the size. Medtronic PLC trades at the lower P/E: 25.6× against 42.3×. Abbott Laboratories grew revenue faster over the last twelve months: 10.0% against 9.77%. Medtronic PLC has the higher net margin (13.9% vs 9.75%) and the higher return on invested capital (6.04% vs 0.00%). Both pay a dividend; Medtronic PLC yields more (2.74% vs 2.22%). Across the 23 metrics below, Medtronic PLC leads on 19 and Abbott Laboratories on 4.
Valuation
Profitability
| Metric | ABT | MDT | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 65.01% | 57.76% |
| Operating margin | 13.78% | 18.08% | (15.07%) |
| Net margin | 9.75% | 13.93% | (14.45%) |
| Free cash flow margin | 0.00% | 16.33% | (3.88%) |
| Return on equity | 0.00% | 10.57% | (10.35%) |
| Return on assets | 0.00% | 5.68% | (17.26%) |
| Return on invested capital | 0.00% | 6.04% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack